IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Atlas Venture Life Science Advisors, LLC

Q3 2025 Holdings

Filed 2025-11-13 | 9 holdings | $752.6M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Kymera Therapeutics, Inc.(KYMR)Common Stock501575104$277.1M4,896,46236.8%
Disc Medicine, Inc.(IRON)Common Stock254604101$141.6M2,142,61718.8%
Dyne Therapeutics, Inc.(DYN)Common Stock26818M108$115.5M9,130,46515.3%
Sionna Therapeutics, Inc.(SION)Common Stock829401108$106.3M3,615,52714.1%
Korro Bio, Inc.(KRRO)Common Stock500946108$54.5M1,137,1497.2%
Day One Biopharmaceuticals, Inc.(DAWN)Common Stock23954D109$45.3M6,430,2576.0%
Generation Bio, Co.(GBIOGBX)Common Stock37148K100$5.1M827,9460.7%
Q32 Bio, Inc.(QTTB)Common Stock746964105$4.1M2,092,1060.6%
ImageneBio, Inc.(IMA)Common Stock45175G207$3.1M377,8140.4%